查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1599693

miRNA 定序和分析市场：按产品和服务、技术、工作流程、最终用户、应用分类 - 2025-2030 年全球预测

miRNA Sequencing & Assay Market by Product & Service (Products, Services), Technology (Nanopore Sequencing, Sanger Sequencing, Sequencing By Oligonucleotide Ligation & Detection), Workflow, End-User, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年miRNA定序与分析市值为3.3335亿美元，预计2024年将达到3.8021亿美元，复合年增长率为14.15%，预计2030年将达到8.4192亿美元。

调查方法miRNA 市场体现了旨在分析微型RNA的广泛技术和方法，而 microRNA 是基因表现的重要调节因子。对 miRNA定序的需求源于其在理解癌症、心血管疾病和神经退化性疾病等疾病方面的潜在应用，为生物标记发现和个人化医疗提供了广阔的前景。其最终用途包括学术研究机构、製药公司、生物技术公司以及从事前沿研究的临床实验室。成长要素包括定序技术的进步，提高了准确性和成本效益，更加关注精准医学中的基因组学，以及增加研究经费。最新的潜在机会在于对非侵入性诊断工具不断增长的需求，这些工具能够透过液态切片早期发现疾病。公司应利用与研究机构的伙伴关係来加速创新并利用人们对 RNA 疗法日益增长的兴趣。然而，市场面临诸如测序仪和检测的高成本、资料解释的复杂性以及监管挑战等限制。此外，还存在资料分析变化和缺乏标准化通讯协定等挑战，需要解决这些挑战才能广泛使用。最佳创新领域包括开发价格实惠且易于使用的定序平台、透过人工智慧整合改进资料分析工具以更好地解释，以及扩展 miRNA 功能的综合资料库。与监管机构的合作将有助于制定标准并解决合规问题。 miRNA 定序和检测市场的本质是动态的，受到技术进步和对精准医疗解决方案不断增长的需求的推动。那些能够适应监管环境、投资研发以降低成本以及加深对 miRNA 在各种疾病中作用的了解的公司，将处于有利地位，并能够保持长期成长和影响力。专注于提高科学家在 miRNA 技术和资料分析方面的技能的培训计划可以进一步推动市场扩张和创新。

主要市场统计
基准年[2023] 33335万美元
预测年份 [2024] 38021万美元
预测年份 [2030] 84192万美元
复合年增长率（%） 14.15%

市场动态：揭示快速发展的 miRNA 定序和分析市场的关键市场洞察

供需的动态交互作用正在改变 miRNA 定序和检测市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 评估 miRNA 序列的各种技术简介
    • 感染疾病流行率不断上升
    • 癌症病例数迅速增加
  • 市场限制因素
    • 缺乏熟练的专业人员
  • 市场机会
    • 具成本效益的定序技术日益普及
    • 遗传学领域研究数量的增加
  • 市场挑战
    • 基础建设初始投资高

波特五力：引领 miRNA 定序与检测市场的策略工具

波特的「五力」框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解 miRNA 定序和检测市场的外部影响

外部宏观环境因素在塑造 miRNA 定序和分析市场的绩效动态方面发挥关键作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解 miRNA 定序和检测市场的竞争格局

对 miRNA 定序和分析市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来发现自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵 miRNA 定序与分析市场供应商的绩效评估

FPNV 定位矩阵是评估 miRNA 定序和分析市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製 miRNA 定序和检测市场的成功之路

对于想要加强在全球市场的影响力的公司来说，对 miRNA 定序和检测市场进行策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 评估 miRNA 序列的各种技术简介
      • 感染疾病传播加剧
      • 癌症发生率迅速增加
    • 抑制因素
      • 缺乏熟练的专业人员
    • 机会
      • 具有成本效益的定序技术越来越受欢迎
      • 遗传学领域研究数量的增加
    • 任务
      • 基础建设初期投资较高
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第 6 章 miRNA 定序与分析市场：依产品和服务分类

  • 产品
    • 装置
    • 文库製备试剂套件
    • 定序耗材
  • 服务

第 7 章 miRNA 定序与分析市场：依技术分类

  • 奈米孔定序
  • 桑格序列
  • 透过寡核苷酸连接和检测定序
  • 单分子即时 (SMRT)定序

第 8 章 miRNA 定序与检测市场：按工作流程

  • 资料分析与存储
  • 准备图书馆
  • 定序

第 9 章 miRNA 定序与分析市场：依最终使用者分类

  • 合约调查机构
  • 製药和生物技术产业
  • 研究/学术机构

第 10 章 miRNA 定序与分析市场：按应用分类

  • 自体免疫疾病
  • 癌症
  • 多聚谷氨酰胺病
  • 思觉失调症

第十一章美洲 miRNA 定序与分析市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区miRNA定序与分析市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲的miRNA定序与检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abcam PLC
  • Bio-Rad Laboratories, Inc.
  • Global Life Sciences Solutions USA LLC
  • HTG Molecular Diagnostics, Inc.
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc
  • Lexogen GmbH
  • Meridian Bioscience Inc
  • New England Biolabs（UK）Ltd.
  • Norgen Biotek Corp.
  • Oxford Nanopore Technologies Limited
  • Rosetta Genomics Ltd.
  • Sigma Aldrich Corp.
  • System Biosciences, LLC
  • Thermo Fisher Scientific Inc.
  • TriLink BioTechnologies, Inc.
Product Code: MRR-0A609A26A984

The miRNA Sequencing & Assay Market was valued at USD 333.35 million in 2023, expected to reach USD 380.21 million in 2024, and is projected to grow at a CAGR of 14.15%, to USD 841.92 million by 2030.

The miRNA Sequencing & Assay market embodies the expansive scope of technologies and methodologies designed to analyze microRNAs, critical regulators of gene expression. The necessity of miRNA sequencing arises from its potential applications in understanding diseases, including cancer, cardiovascular, and neurodegenerative disorders, offering significant prospects for biomarker discovery and personalized medicine. Its end-use scope spans academic research institutions, pharmaceutical and biotechnological companies, and clinical laboratories engaged in cutting-edge research. Influencing growth factors include advancements in sequencing technologies that enhance accuracy and cost-effectiveness, a rising focus on genomics in precision medicine, and expanded research funding. Latest potential opportunities lie in the increasing demand for non-invasive diagnostic tools, enabling early disease detection through liquid biopsies. Companies should exploit partnerships with research institutes to fast-track innovation and capitalize on the rising interest in RNA therapeutics. However, the market faces limitations from the high cost of sequencers and assays, the complexity of data interpretation, and regulatory challenges. Additionally, variability in data analysis and a lack of standardized protocols present challenges that require resolution for more widespread adoption. The best areas for innovation include developing affordable and user-friendly sequencing platforms, improving data analytics tools with AI integration for better interpretation, and expanding comprehensive databases for miRNA function. Collaborations with regulatory agencies could aid in establishing standards and addressing compliance concerns. The nature of the miRNA Sequencing & Assay market is dynamic, driven by technological advancement and the escalating demand for precision healthcare solutions. Companies that can navigate regulatory landscapes, invest in R&D to reduce costs, and broaden the understanding of miRNA's role in various conditions are well-positioned to sustain long-term growth and impact. Enhanced focus on training programs to skill scientists in miRNA technologies and data analysis can further catalyze market expansion and innovation.

KEY MARKET STATISTICS
Base Year [2023] USD 333.35 million
Estimated Year [2024] USD 380.21 million
Forecast Year [2030] USD 841.92 million
CAGR (%) 14.15%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving miRNA Sequencing & Assay Market

The miRNA Sequencing & Assay Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Introduction of various techniques to assess the miRNA sequence
    • Increased prevalence of infectious diseases
    • Surge in the number of cancer incidences
  • Market Restraints
    • Lack of skilled professionals
  • Market Opportunities
    • Growing popularity for cost effective sequencing techniques
    • Increase in the number of research in genetic segment
  • Market Challenges
    • High initial investment on infrastructure

Porter's Five Forces: A Strategic Tool for Navigating the miRNA Sequencing & Assay Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the miRNA Sequencing & Assay Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the miRNA Sequencing & Assay Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the miRNA Sequencing & Assay Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the miRNA Sequencing & Assay Market

A detailed market share analysis in the miRNA Sequencing & Assay Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the miRNA Sequencing & Assay Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the miRNA Sequencing & Assay Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the miRNA Sequencing & Assay Market

A strategic analysis of the miRNA Sequencing & Assay Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the miRNA Sequencing & Assay Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Bio-Rad Laboratories, Inc., Global Life Sciences Solutions USA LLC, HTG Molecular Diagnostics, Inc., Illumina, Inc., Integrated DNA Technologies, Inc, Lexogen GmbH, Meridian Bioscience Inc, New England Biolabs (UK) Ltd., Norgen Biotek Corp., Oxford Nanopore Technologies Limited, Rosetta Genomics Ltd., Sigma Aldrich Corp., System Biosciences, LLC, Thermo Fisher Scientific Inc., and TriLink BioTechnologies, Inc..

Market Segmentation & Coverage

This research report categorizes the miRNA Sequencing & Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product & Service, market is studied across Products and Services. The Products is further studied across Instruments, Library Preparation Kits, and Sequencing Consumables.
  • Based on Technology, market is studied across Nanopore Sequencing, Sanger Sequencing, Sequencing By Oligonucleotide Ligation & Detection, and Single Molecule Real-Time (SMRT) Sequencing.
  • Based on Workflow, market is studied across Data Analysis & Storage, Library Preparation, and Sequencing.
  • Based on End-User, market is studied across Contract Research Organizations, Pharmaceutical & Biotechnology Industry, and Research & Academic Institutes.
  • Based on Application, market is studied across Autoimmune Disease, Cancer, Polyglutamine Diseases, and Schizophrenia.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Introduction of various techniques to assess the miRNA sequence
      • 5.1.1.2. Increased prevalence of infectious diseases
      • 5.1.1.3. Surge in the number of cancer incidences
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing popularity for cost effective sequencing techniques
      • 5.1.3.2. Increase in the number of research in genetic segment
    • 5.1.4. Challenges
      • 5.1.4.1. High initial investment on infrastructure
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. miRNA Sequencing & Assay Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Products
    • 6.2.1. Instruments
    • 6.2.2. Library Preparation Kits
    • 6.2.3. Sequencing Consumables
  • 6.3. Services

7. miRNA Sequencing & Assay Market, by Technology

  • 7.1. Introduction
  • 7.2. Nanopore Sequencing
  • 7.3. Sanger Sequencing
  • 7.4. Sequencing By Oligonucleotide Ligation & Detection
  • 7.5. Single Molecule Real-Time (SMRT) Sequencing

8. miRNA Sequencing & Assay Market, by Workflow

  • 8.1. Introduction
  • 8.2. Data Analysis & Storage
  • 8.3. Library Preparation
  • 8.4. Sequencing

9. miRNA Sequencing & Assay Market, by End-User

  • 9.1. Introduction
  • 9.2. Contract Research Organizations
  • 9.3. Pharmaceutical & Biotechnology Industry
  • 9.4. Research & Academic Institutes

10. miRNA Sequencing & Assay Market, by Application

  • 10.1. Introduction
  • 10.2. Autoimmune Disease
  • 10.3. Cancer
  • 10.4. Polyglutamine Diseases
  • 10.5. Schizophrenia

11. Americas miRNA Sequencing & Assay Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific miRNA Sequencing & Assay Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa miRNA Sequencing & Assay Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam PLC
  • 2. Bio-Rad Laboratories, Inc.
  • 3. Global Life Sciences Solutions USA LLC
  • 4. HTG Molecular Diagnostics, Inc.
  • 5. Illumina, Inc.
  • 6. Integrated DNA Technologies, Inc
  • 7. Lexogen GmbH
  • 8. Meridian Bioscience Inc
  • 9. New England Biolabs (UK) Ltd.
  • 10. Norgen Biotek Corp.
  • 11. Oxford Nanopore Technologies Limited
  • 12. Rosetta Genomics Ltd.
  • 13. Sigma Aldrich Corp.
  • 14. System Biosciences, LLC
  • 15. Thermo Fisher Scientific Inc.
  • 16. TriLink BioTechnologies, Inc.

LIST OF FIGURES

  • FIGURE 1. MIRNA SEQUENCING & ASSAY MARKET RESEARCH PROCESS
  • FIGURE 2. MIRNA SEQUENCING & ASSAY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. MIRNA SEQUENCING & ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. MIRNA SEQUENCING & ASSAY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MIRNA SEQUENCING & ASSAY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MIRNA SEQUENCING & ASSAY MARKET DYNAMICS
  • TABLE 7. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY LIBRARY PREPARATION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SEQUENCING CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SEQUENCING BY OLIGONUCLEOTIDE LIGATION & DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SINGLE MOLECULE REAL-TIME (SMRT) SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY DATA ANALYSIS & STORAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY LIBRARY PREPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY AUTOIMMUNE DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY POLYGLUTAMINE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. MIRNA SEQUENCING & ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 283. MIRNA SEQUENCING & ASSAY MARKET, FPNV POSITIONING MATRIX, 2023